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background
 
Silent brain infarcts are frequently seen on magnetic resonance imaging (MRI) in healthy
elderly people and may be associated with dementia and cognitive decline.
 
methods
 
We studied the association between silent brain infarcts and the risk of dementia and
cognitive decline in 1015 participants of the prospective, population-based Rotterdam
Scan Study, who were 60 to 90 years of age and free of dementia and stroke at base line.
Participants underwent neuropsychological testing and cerebral MRI at base line in
1995 to 1996 and again in 1999 to 2000 and were monitored for dementia throughout
the study period. We performed Cox proportional-hazards and multiple linear-regres-
sion analyses, adjusted for age, sex, and level of education and for the presence or ab-
sence of subcortical atrophy and white-matter lesions.
 
results
 
During 3697 person-years of follow-up (mean per person, 3.6 years), dementia devel-
oped in 30 of the 1015 participants. The presence of silent brain infarcts at base line
more than doubled the risk of dementia (hazard ratio, 2.26; 95 percent confidence in-
terval, 1.09 to 4.70). The presence of silent brain infarcts on the base-line MRI was as-
sociated with worse performance on neuropsychological tests and a steeper decline in
global cognitive function. Silent thalamic infarcts were associated with a decline in mem-
ory performance, and nonthalamic infarcts with a decline in psychomotor speed. When
participants with silent brain infarcts at base line were subdivided into those with and
those without additional infarcts at follow-up, the decline in cognitive function was re-
stricted to those with additional silent infarcts.
 
conclusions
 
Elderly people with silent brain infarcts have an increased risk of dementia and a
steeper decline in cognitive function than those without such lesions.
abstract
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ementia is a major health prob-
 
lem in Western countries. Dementia will
develop in one in four 55-year-olds,
 
1
 
 and
the number of patients with dementia will rise as life
expectancy increases. Evidence has accumulated
that vascular abnormalities have a role in the devel-
opment of dementia. Patients with stroke are at in-
creased risk for both vascular dementia and Alzhei-
mer’s disease.
 
2-4
 
 People who were found at autopsy
to have lacunar cerebral infarcts were more likely to
have had dementia than those without infarcts, and
fewer pathological findings of Alzheimer’s disease
were needed in persons with such infarcts for clin-
ical symptoms of dementia to be present.
 
5,6
 
 Patients
with Alzheimer’s disease more frequently have
asymptomatic (i.e., silent) brain infarcts on magnet-
ic resonance imaging (MRI) than do control sub-
jects without dementia.
 
7,8
 
 The prevalence of silent
brain infarcts is also high in elderly populations
without dementia,
 
9-11
 
 but little is known about
their prognostic relevance. We therefore examined
the relation between silent brain infarcts and the
risk of dementia and cognitive decline in the gen-
eral population.
 
participants
 
The Rotterdam Scan Study is a prospective, popu-
lation-based cohort study designed to study the
causes and consequences of brain changes in the
elderly.
 
12
 
 In 1995 to 1996, we randomly selected
1717 participants 60 to 90 years of age, with stratifi-
cation according to age (in five-year groups) and sex,
from two ongoing population-based studies.
 
13,14
 
A total of 1077 elderly people without dementia par-
ticipated (63 percent). Participants were significant-
ly younger and more highly educated and performed
better on the Mini–Mental State Examination than
nonparticipants.
 
15
 
 The medical ethics committee
of the Erasmus Medical Center approved the study,
and each participant gave written informed consent.
The base-line examination in 1995 to 1996 com-
prised a structured interview, physical examination,
blood sampling, and neuropsychological tests at the
research center, as well as a cerebral MRI scan. For
the present study we excluded 62 participants with
a history of stroke before the base-line evaluation
(Fig. 1).
 
16
 
 We monitored all 1015 participants
throughout the study by reviewing medical records
from their general practitioners after base line for
death and major complications, including cognitive
problems, dementia, stroke, and transient ischemic
attack. In 1999 to 2000, we reinvited 914 of the 1015
participants for a second examination, of whom 739
participated (81 percent) (Fig. 1). The remaining
101 participants were not reinvited, for the follow-
ing reasons: 75 had died, 15 had been institutional-
ized for dementia, 7 had already been examined in
1999 as part of the regular examination for the Rot-
d
methods
 
Figure 1. Flow Diagram of the Study Population.
 
The various study samples are indicated by double-lined 
boxes. MRI denotes magnetic resonance imaging.
1077 Underwent MRI in 1995–1996
1015 Were free of stroke,
1995–1996
739 Underwent 2nd examination,
1999–2000
62 With history of stroke excluded
101 Not eligible for 2nd examination,
1999–2000
175 Declined 2nd examination,
1999–2000
619 Free of stroke,
1999–2000
10 With symptomatic infarcts
excluded, 1999–2000
629 Underwent 2nd MRI
1999–2000
13 Not eligible for 2nd MRI,
1999–2000
97 Declined 2nd MRI,
1999–2000
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terdam Study,
 
14
 
 3 had moved abroad, and 1 could
not be reached. 
People who were ineligible or who declined to
undergo the second examination were significant-
ly older, were less highly educated, and performed
worse on the neuropsychological tests at base line
than participants in the second examination. People
who declined to undergo the second examination
did not differ significantly from those who partic-
ipated with respect to the presence or absence of si-
lent brain infarcts at base line, whereas ineligible
participants had a nonsignificantly higher preva-
lence of silent brain infarcts than participants (ab-
solute age- and sex-adjusted difference, 5 percent;
95 percent confidence interval, ¡3 to 14 percent).
Thirteen of the 739 participants were ineligible to
undergo a second MRI of the brain because of a
contraindication to MRI, and 97 declined to un-
dergo the procedure. In total, 629 of the 901 eligi-
ble participants (70 percent) underwent a second
MRI in 1999 to 2000.
 
cerebral infarcts and other mri measures
 
All 1015 participants underwent MRI of the brain at
base line in 1995 to 1996. We made axial T
 
1
 
-weight-
ed, T
 
2
 
-weighted, and proton-density–weighted
scans on 1.5-Tesla MRI scanners (MR Gyroscan,
Philips, or MR VISION, Siemens).
 
11
 
 In 1999 to
2000, 629 participants underwent a second MRI
with use of the MR VISION scanner and the same
sequences.
The presence of brain infarcts was rated similarly
at base line and follow-up. We defined brain infarcts
as areas of focal hyperintensity on T
 
2
 
-weighted im-
ages that were at least 3 mm in diameter. Proton-
density scans were used to distinguish infarcts from
dilated perivascular spaces. Areas of hyperintensity
in the white matter also had to have corresponding
prominent hypointensity on T
 
1
 
-weighted images,
in order to distinguish them from cerebral white-
matter lesions. A single trained physician who was
unaware of the patients’ history of stroke and tran-
sient ischemic attack scored infarcts on both the
base-line and second MRI with respect to their lo-
cation and size. An intrarater study for detecting
infarcts (110 images randomly selected from both
scanners) showed good agreement (
 
k
 
=0.80).
We obtained information on any history of stroke
and transient ischemic attack from the participants
themselves and by checking medical records of all
participants, independently of their MRI results. An
experienced neurologist subsequently reviewed the
participants’ medical history and scans and catego-
rized infarcts as silent or symptomatic. We defined
silent brain infarcts as evidence on MRI of one or
more infarcts, without a history of a (correspond-
ing) stroke or transient ischemic attack. If a prior
stroke or transient ischemic attack did correspond
with a lesion, the latter was defined as a sympto-
matic infarct. The intrarater reliability for the clas-
sification of infarcts as silent or symptomatic was
excellent (
 
k
 
=1.0). If participants had both sympto-
matic and silent infarcts, they were included in the
group with symptomatic infarcts.
White-matter lesions and subcortical atrophy of
the brain were rated on the base-line MRI scans.
 
12
 
White-matter lesions were considered present if
they were hyperintense on proton-density and
T
 
2
 
-weighted images, without prominent hypointen-
sity on T
 
1
 
-weighted scans. The severity of periven-
tricular white-matter lesions was determined by
adding three region-specific scores (grades ranged
from 0 to 9, with higher grades indicating greater
severity). The volume of subcortical white-matter
lesions was approximated on the basis of the num-
ber and size of lesions (volume range, 0 to 29.5 ml).
The severity of subcortical atrophy of the brain was
estimated by calculating the ratio of ventricle to
brain (the average of assessments at the frontal
and occipital horns and the caudate nucleus) on
T
 
1
 
-weighted images.
 
17
 
 Both intrareader and inter-
reader studies (100 of each) showed good-to-
excellent agreement.
 
12
 
dementia
 
All participants were free of dementia at base line.
We screened all participants for dementia at follow-
up using the Mini–Mental State Examination and
the Geriatric Mental State Schedule.
 
1
 
 Participants
who were positive at screening underwent addition-
al cognitive testing with the Cambridge Mental Dis-
orders of the Elderly Examination. People who were
then thought to have dementia were examined by a
neurologist and underwent extensive neuropsycho-
logical testing. In addition, we continually moni-
tored the medical records of all participants at their
general practitioners’ offices and the Regional In-
stitute for Ambulatory Mental Health Care to obtain
information on newly diagnosed dementia until
March 1, 2000. Dementia and its subtypes were di-
agnosed by a panel that reviewed all available infor-
mation according to standardized criteria.
 
18-20
 
 The
onset of dementia was defined as the date on which
the clinical symptoms allowed the diagnosis of de-
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mentia to be made. We had complete follow-up
data for dementia on all participants through our
system of monitoring general practitioners.
 
cognitive decline
 
Participants underwent the following neuropsycho-
logical tests at the base-line examination: the Mini–
Mental State Examination, the 15-word verbal-
learning test, the Stroop test, the Paper-and-Pencil
Memory Scanning Task, and the Letter–Digit Sub-
stitution Task.
 
15
 
 We used alternative versions of the
same neuropsychological tests at the second exam-
ination. For each participant, we calculated z scores
(individual test score minus mean test score divid-
ed by the standard deviation) for the neuropsycho-
logical tests at base line and at follow-up using the
mean and standard deviation of the base-line tests.
We constructed compound scores for memory per-
formance by averaging the z scores of the total of
three immediate recall trials and the delayed-recall
trial of the 15-word verbal-learning test. The com-
pound score for psychomotor speed was the average
of the z scores for the reading subtask of the Stroop
test, the one-letter subtask of the Paper-and-Pencil
Memory Scanning Task, and the Letter–Digit Sub-
stitution Task. The compound score for global cog-
nitive function was constructed by calculating the
average of the z scores for all the above tests.
 
15
 
 Cog-
nitive decline was calculated by subtracting the
z scores for memory performance, psychomotor
speed, and global cognitive function at follow-up
from the z scores at base line.
 
statistical analysis
 
First, we used Cox proportional-hazards regres-
sion analysis to examine the relation between the
presence of silent brain infarcts at base line and the
risk of subsequent dementia in the 1015 partici-
pants who were free of dementia and stroke at base
line. The duration of follow-up was calculated
from the date of the MRI at base line until death,
the diagnosis of dementia, or the end of follow-up,
whichever came first. We also investigated the as-
sociation of white-matter lesions and subcortical
atrophy of the brain with dementia and whether
these structural changes in the brain affected the
relation between silent brain infarcts and demen-
tia. Second, we estimated the association between
the presence of silent brain infarcts at base line and
subsequent cognitive decline by multiple linear-
regression analysis in the subsample of 739 partic-
ipants who underwent neuropsychological tests at
follow-up. We also investigated whether this rela-
tion with cognitive decline differed between silent
infarcts in the thalamus and infarcts elsewhere, be-
cause thalamic nuclei are involved in storage and
short-term memory.
 
21,22
 
 Third, we examined the
contribution of newly detected silent infarcts to the
rate of cognitive decline. This analysis was based
on 619 participants without symptomatic infarcts
on the second MRI (Fig. 1).
We adjusted all analyses for age, sex, and level of
education. In the analyses of cognitive decline, we
also adjusted for the interval between the two sets
of neuropsychological tests.
During 3697 person-years of follow-up (mean per
person, 3.6 years), dementia developed in 30 par-
ticipants (3 percent), 26 of whom had Alzheimer’s
disease (1 with cerebrovascular disease), 2 vascular
dementia, and 1 multisystem atrophy; in 1, the sub-
type was unknown. Four patients with dementia
died, but no autopsy was performed.
Table 1 shows the base-line characteristics of
the participants. Eleven of the 217 participants
with silent brain infarcts at base line had cortical
infarcts, 202 had lacunar infarcts — 171 in the ba-
sal ganglia and 31 in the subcortex — and 4 had in-
farcts in the cerebellum or brainstem. Fourteen of
the 30 participants in whom dementia developed
had one or more silent brain infarcts present on the
base-line MRI, 7 of whom had multiple infarcts. 
The presence of silent brain infarcts at base line
more than doubled the risk of dementia, and this
result remained largely unchanged after adjustment
for the severity of white-matter lesions and subcor-
tical atrophy (Table 2). A greater severity of periven-
tricular white-matter lesions was also associated
with an increased risk of dementia (Table 2), as was
a greater severity of subcortical atrophy of the brain
(hazard ratio per increase of 1 SD in severity, 1.78;
95 percent confidence interval, 1.26 to 2.51). 
There was no significant difference in risk be-
tween participants with Mini–Mental State Exami-
nation scores below 26 and those with a score of 26
or above at base line or between carriers of the apo-
lipoprotein E 
 
e
 
4 allele and noncarriers. The exclu-
sion of participants who used aspirin or oral antico-
agulants at base line did not materially change the
results. Nineteen of the 30 participants in whom
dementia developed underwent a second cerebral
MRI or computed tomographic scan; a symptomat-
results
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ic infarct was found in 3 (16 percent) and a new si-
lent brain infarct was found in 4 (21 percent). This
rate was higher than that among the 618 partici-
pants without dementia at follow-up, of whom
8 (1 percent) had a symptomatic brain infarct and
71 (11 percent) a silent brain infarct on the second
MRI scan.
Global cognitive function was significantly worse
in participants with silent brain infarcts on the base-
line MRI than in those without such infarcts (adjust-
ed mean difference in z score, ¡0.11; 95 percent
confidence interval, ¡0.20 to ¡0.01). The presence
of silent brain infarcts at base line was associated
with a steeper decline in cognitive function (Table
3). The presence of multiple silent infarcts showed
a stronger relation with cognitive decline than the
presence of single silent infarcts (adjusted mean dif-
ference in z score for multiple infarcts, ¡0.34; 95
percent confidence interval, ¡0.51 to ¡0.17; and
 
* Plus–minus values are unadjusted means ±SD. MRI denotes magnetic resonance imaging.
† The score on the Mini–Mental State Examination (MMSE) can range from 0 to 30, with higher scores indicating better 
cognitive function.
‡ The apolipoprotein E (
 
APOE
 
) genotype was not determined in 97 of the 1015 participants, 63 of the 739 who underwent 
 
the second examination, and 55 of the 619 who underwent the second MRI.
 
Table 1. Base-Line Characteristics of All Participants Who Were Free of Dementia and Stroke in 1995 to 1996, 
Those Who Underwent the Second Neuropsychological Examination, and Those Who Underwent the Second MRI Scan 
in 1999 to 2000.*
Characteristic
All Participants
(N=1015)
Participants Who
Underwent 2nd Examination
(N=739)
Participants Who
Underwent 2nd MRI
(N=619)
 
Age — yr 72.1±7.4 70.9±7.0 70.7±7.0
Women — no. (%) 526 (52) 390 (53) 320 (52)
Primary education only — no. (%) 357 (35) 235 (32) 191 (31)
MMSE score† 27.4±2.2 27.6±2.1 27.6±2.0
Hypertension — no. (%) 517 (51) 357 (48) 291 (47)
Diabetes mellitus — no. (%) 66 (7) 42 (6) 33 (5)
Use of aspirin — no. (%) 109 (11) 71 (10) 49 (8)
Use of oral anticoagulants — no. (%) 41 (4) 24 (3) 20 (3)
 
APOE
 
 
 
e
 
4 carriers — no. (%)‡ 267 (29) 206 (30) 171 (30)
Silent brain infarcts — no. (%)
Thalamic
Nonthalamic
217 (21)
32 (3)
185 (18)
148 (20)
20 (3)
128 (17)
116 (19)
14 (2)
102 (16)
White-matter lesions
Periventricular — grade
Subcortical — ml
2.3±2.2
1.3±2.8
2.1±2.1
1.1±2.4
2.0±2.1
1.1±2.5
Ratio of subcortical brain atrophy 0.32±0.04 0.31±0.04 0.31±0.04
 
* The magnetic resonance imaging (MRI) measures adjusted for were presence 
or absence of silent brain infarcts, severity of periventricular and subcortical 
 
white-matter lesions, and severity of subcortical brain atrophy.
 
Table 2. Relation between the Presence of Silent Brain Infarcts at Base Line, 
the Severity of Periventricular and Subcortical White-Matter Lesions, 
and the Risk of Dementia.
Variable Hazard Ratio (95% Confidence Interval)
 
Adjusted for Age,
Sex, and Level
of Education
Adjusted for Age, Sex,
Level of Education,
and MRI Measures*
Silent brain infarcts (yes vs. no) 2.26 (1.09–4.70) 2.03 (0.91–4.55)
Severity of periventricular white-
matter lesions (per SD in-
crease)
1.59 (1.13–2.25) 1.47 (0.92–2.35)
Severity of subcortical white-
matter lesions (per SD in-
crease)
1.21 (0.96–1.53) 0.92 (0.65–1.29)
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for single infarcts, ¡0.07; 95 percent confidence in-
terval, ¡0.20 to 0.06). Silent infarcts in the thalamus
were associated with a greater decline in memory
performance, whereas infarcts located elsewhere re-
sulted in a greater decline in psychomotor speed
(Table 3). There was no association between the
presence of silent brain infarcts at base line and a
decline in the Mini–Mental State Examination score
(adjusted mean difference in the score, ¡0.01; 95
percent confidence interval, ¡0.44 to 0.33).
When participants were subdivided into four
groups according to the presence or absence of si-
lent brain infarcts on the base-line and follow-up
MRI, the decline in cognitive function was restricted
to those with new silent brain infarcts on the follow-
up scan, regardless of whether they had silent in-
farcts at base line (Fig. 2). Memory performance im-
proved for all participants, as expected owing to
the learning effect. There were no significant chang-
es in scores on the Mini–Mental State Examination
among the various groups.
We found that the presence of silent brain infarcts
on MRI at base line in the general population dou-
bled the risk of dementia. People with silent infarcts
had a steeper decline in cognitive function than
those without silent infarcts, but this decline was
confined to people who had additional silent brain
infarcts after base line.
The strengths of this study are the large number
of elderly participants and its population-based
design. Furthermore, we had no losses to follow-
up for the analyses of dementia. Notwithstanding
good-to-excellent intrareader agreement, we still
may have incorrectly identified brain infarcts or mis-
classified infarcts as silent or symptomatic. How-
ever, because silent brain infarcts were identified
and classified in a blinded fashion from data on de-
mentia and neuropsychological tests, any misclas-
sification would have resulted in an underestima-
tion of the associations.
The dementia diagnoses in our study were clini-
cal diagnoses. We intentionally refrained from an-
alyzing subtypes of dementia, because a distinction
based on clinical information is hard to make, es-
pecially in elderly people, in whom dementia often
is a heterogeneous disorder. There is increasing ev-
idence that vascular factors may contribute to the
development of Alzheimer’s disease.
 
23,24
 
 After a
stroke, dementia, including Alzheimer’s disease,
develops in approximately 30 percent of patients
with symptomatic infarcts.
 
2-4
 
 We found that silent
brain infarcts increase the risk of dementia, the ma-
jority of cases of which in our study were of the Alz-
heimer’s subtype. Furthermore, we showed that a
greater severity of periventricular white-matter le-
sions, also thought to result from small-vessel dis-
ease, was associated with an increased risk of de-
mentia. 
Our findings of a large number of new infarcts
in the participants in whom dementia developed
and a steeper decline in cognition in those with a
new infarct support the notion that people with si-
lent brain infarcts are at high risk for additional in-
farcts, both silent and symptomatic,
 
25
 
 which may
contribute to dementia. Perhaps an infarct in a brain
already affected by Alzheimer’s disease–related ab-
normalities further impairs cognition, leading to
discussion
 
* Values are the mean differences in the z scores between follow-up and base line, with 95 percent confidence intervals 
(CIs) between those with and those without silent brain infarcts, adjusted for age, sex, level of education, and interval 
 
between neuropsychological tests. A positive value indicates an increase in the z score.
 
Table 3. Association between the Presence of Silent Brain Infarcts on Magnetic Resonance Imaging in 1995–1996 
and Subsequent Cognitive Decline.*
Variable Silent Brain Infarcts
 
All Thalamic Nonthalamic
 
decline in z score (95% CI)
 
Memory performance ¡0.01 (¡0.16 to 0.15) ¡0.50 (¡0.87 to ¡0.13) 0.06 (¡0.10 to 0.23)
Psychomotor speed ¡0.19 (¡0.34 to ¡0.04) ¡0.11 (¡0.36 to 0.13) ¡0.20 (¡0.36 to ¡0.05)
Global cognitive function ¡0.15 (¡0.27 to ¡0.02) ¡0.28 (¡0.50 to ¡0.06) ¡0.13 (¡0.26 to 0.001)
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clinically evident dementia. This notion is support-
ed by autopsy findings showing that fewer plaques
and tangles led to clinical Alzheimer’s disease in
the presence of lacunar infarcts.
 
5
 
 Alternatively, si-
lent brain infarcts may trigger the development of
senile plaques and neurofibrillary tangles or reflect
cerebral vulnerability or a certain vascular risk pro-
file that enhances the abnormalities associated with
Alzheimer’s disease. However, several clinicopath-
ological studies found that patients with Alzhei-
mer’s disease who had infarcts had a similar
amount of plaques and tangles or even fewer than
those without infarcts.
 
26-29
 
We found that silent brain infarcts — those
without relevant stroke symptoms — are associat-
ed with worse cognition, confirming the results of
a cross-sectional study.
 
9
 
 Recently, we reported that
the presence of periventricular white-matter lesions
is associated with a steeper cognitive decline,
 
30
 
 and
we have now found that this is also true for silent
brain infarcts. That the relation between infarcts
and cognitive decline was stronger for multiple in-
farcts than for single infarcts strengthens these find-
ings. Furthermore, we found that this decline in
cognitive function was confined to persons with in-
cident silent infarcts, which may suggest a stepwise
decline after an infarct occurs.
The reason that we found no relation between a
decline in the score on the Mini–Mental State Ex-
amination and the presence of silent brain infarcts
is probably that this test, although useful as a
screening tool for dementia, is not a very sensitive
means of detecting subtle changes in cognitive func-
tion. The Cardiovascular Health Study did find an
association between evidence of infarcts on MRI
and a decline in a modified Mini–Mental State Ex-
amination score, which comprised 100 rather than
30 questions and examined a broader range of cog-
nitive function.
 
31
 
 Furthermore, we found that the
decline in different cognitive domains varied with
the location of silent brain infarcts on MRI. Stra-
tegic infarcts in the thalamus, which is involved in
storage and short-term memory,
 
21,22
 
 were associ-
ated with a worse performance in memory tasks. 
Our finding that in both participants with and
those without silent brain infarcts memory perform-
ance improved at the second examination may be
explained by a learning effect.
 
32 
 
This learning effect
does not seem to have a major role in tests specific
for psychomotor speed. The presence of silent in-
 
Figure 2. Mean Change in Memory Performance, Psy-
chomotor Speed, and Global Cognitive Function among 
Participants with and Those without Silent Brain Infarcts 
on Magnetic Resonance Imaging at Base Line (1995 to 
1996) and at Follow-up (1999 to 2000), after Adjustment 
for Age, Sex, Level of Education, and Interval between 
Neuropsychological Tests.
 
Bars are 95 percent confidence intervals. P values are for 
the comparison with participants who did not have in-
farcts at base line or follow-up.
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farcts that were not in the thalamus resulted in a de-
cline in psychomotor speed. These infarcts proba-
bly interrupt various connecting fibers in the white
matter that are involved in these psychomotor tasks.
In conclusion, the presence of silent brain in-
farcts on MRI identifies persons at increased risk for
dementia, probably because these people continue
to have additional brain infarcts, both silent and
symptomatic, that decrease their cognitive function.
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